tianeptine (Stablon) Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Tianeptine, sold under the brand names Stablon, Tatinol, and Coaxil among others, is an atypical tricyclic antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.   Wikipedia

Chemistry

  • SMILES: CN1c2ccccc2C(NCCCCCCC(=O)O)c3ccc(Cl)cc3S1(=O)=O
  • InChIKey: JICJBGPOMZQUBB-UHFFFAOYSA-N
  • Mol. Mass: 436.96
  • ALogP: 4.19
  • ChEMBL Molecule:
    tianeptine  
More Chemistry

Pharmacology

Alternative names

(3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2)thiazepin-11-yl)-7-aminoheptanoic acid | ardix brand of tianeptine, monosodium salt | coaxil | stablon | tianeptine | tianeptine, (+-)-isomer | tianeptine monosodium | tianeptine, monosodium salt | tianeptine, monosodium salt, (+-)-isomer | tianeptine sodium

Organizations (7)

Research & Development (7)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (4)

Approved Indications (1)


 

Depression

Experimental Indications - Clinical Trial Phases 1-4 (3)


 

Bipolar Disorder (Phase 3)

Depressive Disorder, Major (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial Organizations: 7

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue